Investigation of Sex Hormone Levels in Chinese Women With Invasive Breast Cancer
NCT02263846 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1183
Last updated 2015-04-13
Summary
This study is to investigate sex hormones levels of Chinese patients with invasive breast cancer.The aim is to analyze biochemical monitoring results of premenopausal and postmenopausal patients to facilitate determination of menopausal status and propose clinical application.
Conditions
Sponsors & Collaborators
-
Chinese Anti-Cancer Association
collaborator OTHER -
Affiliated Hospital to Academy of Military Medical Sciences
lead OTHER
Principal Investigators
-
Santai Song · Affiliated Hospital to Academy of Military Medical Sciences
Eligibility
- Min Age
- 20 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-11-30
- Primary Completion
- 2013-07-31
- Completion
- 2013-07-31
More Related Trials
-
A Prospective Observational Study About Adjuvant or Neoadjuvant Chemotherapy Related Adverse Effects in Premenopausal Breast Cancer Patients
NCT03543059 ·Status: UNKNOWN
-
Comparative Study for the Degree of Biological Changes After Short-term 2 Weeks and 4 Weeks Preoperative Endocrine Therapy in Luminal Breast Cancer
NCT04023292 ·Status: UNKNOWN ·Phase: PHASE2
-
Safety of OFS Combined With AI Endocrine Therapy in Chinese Premenopausal Breast Cancer Patients
NCT02440230 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the Relationship of TOP2α Expression and Effect of Non Dose-dense Chemotherapy for Breast Cancer
NCT02506361 ·Status: RECRUITING
-
Impact of Obesity on the Efficacy of Endocrine Therapy With Aromatase Inhibitors
NCT01758146 ·Status: UNKNOWN ·Phase: PHASE3
-
Research of Zoledronic Acid and Aromatase Inhibitors as Adjuvant Therapy to Breast Cancer
NCT01654367 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Quality of Life in Chinese Postmenopausal HR(+) Early Breast Cancer (EBC) Patients During Adjuvant Aromatase Inhibitors(AIs) Treatment
NCT01144572 ·Status: COMPLETED
-
Gonadotropin-Releasing Hormone Agonist for the Preservation of Ovarian Function During Chemotherapy in Premenopausal Breast Cancer
NCT02483767 ·Status: COMPLETED ·Phase: PHASE3
-
Chidamide Combined With Exemestane (+/- Goserelin) Versus Neoadjuvant Chemotherapy in Patients of Stage II-III HR-positive/HER2-negative Breast Cancer
NCT05253066 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Safety of Toremifene and Tamoxifen Therapy in Premenopausal Patients With Operable Breast Cancer
NCT02344940 ·Status: COMPLETED ·Phase: PHASE4
-
Maintenance Hormone Therapy for Postmenopausal HR Positive Advanced Breast Cancer
NCT02000193 ·Status: UNKNOWN ·Phase: PHASE2
-
Efficacy of High Dose Tamoxifen to Advanced Hormone Receptor-High Expressed Breast Cancer
NCT03045653 ·Status: COMPLETED ·Phase: PHASE2
-
Premenopausal Patient With Hormone Responsive, HER2 Negative, Lymph Node Positive Breast Cancer
NCT01622361 ·Status: UNKNOWN ·Phase: PHASE3
-
Steroid Aromatase Inhibitors Versus Progestogens for nSAID-resistanced Late Stage Breast Cancer
NCT02161315 ·Status: UNKNOWN
-
Effects of Adjuvant Endocrine Therapy With Aromatase Inhibitors on the Postoperative Lipid Levels in Postmenopausal Breast Cancer Patients
NCT02765373 ·Status: UNKNOWN
-
The Benefits of Continued Use of Ovarian Function Suppression After 5 Years
NCT06050109 ·Status: RECRUITING
-
Compliance to a Hormone Therapy Regimen in Breast Cancer
NCT00666822 ·Status: COMPLETED
-
Hormone Therapy Or Chemotherapy Before Surgery Based on Gene Expression Analysis in Treating Patients With Breast Cancer
NCT01293032 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Tamoxifen Versus Toremifene in CYP2D6 IM/PM of Premenopausal Patients With ER-positive Early Breast Cancer
NCT03351062 ·Status: RECRUITING ·Phase: PHASE3
-
CDK4/6 Inhibitors Combined With Standard Adjuvant Endocrine Therapy in High-Risk, HR+/HER2+ Early Breast Cancer Patients(CHESS)
NCT07019363 ·Status: RECRUITING ·Phase: PHASE3
-
Effect of Endocrine Therapy Duration on Clinical Outcome of Patients With HR+ Intraductal Carcinoma of the Breast
NCT04666805 ·Status: UNKNOWN
-
Neoadjuvant Chemotherapy With or Without GnRH Agonist for Premenopausal Triple-negative Early Breast Cancer Patients
NCT06225284 ·Status: RECRUITING ·Phase: PHASE2
-
Breast Density Change Predicting Response to Adjuvant Aromatase Inhibitor
NCT01765049 ·Status: ACTIVE_NOT_RECRUITING
-
A Prospective Observational Study About Adjuvant or Neoadjuvant Chemotherapy Related Adverse Effects in Postmenopausal Breast Cancer Patients
NCT03543072 ·Status: UNKNOWN
-
Adjuvant Toremifene With or Without Goserrelin in Premenopausal Women With Stage I-IIIA, Hormonal Receptor Positive Breast Cancer Accompanied With or Without Chemotherapy Induced Amenorrhoea
NCT02132390 ·Status: UNKNOWN ·Phase: PHASE3